These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32285370)

  • 21. Advances in Microfluidic Blood-Brain Barrier (BBB) Models.
    Oddo A; Peng B; Tong Z; Wei Y; Tong WY; Thissen H; Voelcker NH
    Trends Biotechnol; 2019 Dec; 37(12):1295-1314. PubMed ID: 31130308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascularized microfluidic platforms to mimic the tumor microenvironment.
    Michna R; Gadde M; Ozkan A; DeWitt M; Rylander M
    Biotechnol Bioeng; 2018 Nov; 115(11):2793-2806. PubMed ID: 29940072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microfluidics devices for sports: A review on technology for biomedical application used in fields such as biomedicine, drug encapsulation, preparation of nanoparticles, cell targeting, analysis, diagnosis, and cell culture.
    Lei X; Ye W; Safdarin F; Baghaei S
    Tissue Cell; 2024 Apr; 87():102339. PubMed ID: 38432127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microfluidic systems to study tissue barriers to immunotherapy.
    Ramirez A; Amosu M; Lee P; Maisel K
    Drug Deliv Transl Res; 2021 Dec; 11(6):2414-2429. PubMed ID: 34215998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumour-vessel-on-a-chip models for drug delivery.
    Caballero D; Blackburn SM; de Pablo M; Samitier J; Albertazzi L
    Lab Chip; 2017 Nov; 17(22):3760-3771. PubMed ID: 28861562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mimicking and surpassing the xenograft model with cancer-on-chip technology.
    Komen J; van Neerven SM; van den Berg A; Vermeulen L; van der Meer AD
    EBioMedicine; 2021 Apr; 66():103303. PubMed ID: 33773183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerating innovation and commercialization through standardization of microfluidic-based medical devices.
    Reyes DR; van Heeren H; Guha S; Herbertson L; Tzannis AP; Ducrée J; Bissig H; Becker H
    Lab Chip; 2021 Jan; 21(1):9-21. PubMed ID: 33289737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of Leukocyte Behaviors on Microfluidic Chips.
    Liu Y; Yang Q; Cao L; Xu F
    Adv Healthc Mater; 2019 Feb; 8(4):e1801406. PubMed ID: 30672149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of microfluidics for the preparation of nanoparticles as advanced drug delivery systems.
    Martins JP; Torrieri G; Santos HA
    Expert Opin Drug Deliv; 2018 May; 15(5):469-479. PubMed ID: 29508630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simulation of complex transport of nanoparticles around a tumor using tumor-microenvironment-on-chip.
    Kwak B; Ozcelikkale A; Shin CS; Park K; Han B
    J Control Release; 2014 Nov; 194():157-67. PubMed ID: 25194778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microfluidics for studying metastatic patterns of lung cancer.
    Ruzycka M; Cimpan MR; Rios-Mondragon I; Grudzinski IP
    J Nanobiotechnology; 2019 May; 17(1):71. PubMed ID: 31133019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lab-on-a-chip synthesis of inorganic nanomaterials and quantum dots for biomedical applications.
    Krishna KS; Li Y; Li S; Kumar CS
    Adv Drug Deliv Rev; 2013 Nov; 65(11-12):1470-95. PubMed ID: 23726944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A versatile and robust microfluidic platform toward high throughput synthesis of homogeneous nanoparticles with tunable properties.
    Liu D; Cito S; Zhang Y; Wang CF; Sikanen TM; Santos HA
    Adv Mater; 2015 Apr; 27(14):2298-304. PubMed ID: 25684077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in microfluidics for drug discovery.
    Lombardi D; Dittrich PS
    Expert Opin Drug Discov; 2010 Nov; 5(11):1081-94. PubMed ID: 22827746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microfluidic technologies for vasculature biomimicry.
    Hu C; Chen Y; Tan MJA; Ren K; Wu H
    Analyst; 2019 Jul; 144(15):4461-4471. PubMed ID: 31162494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microfluidic technologies for anticancer drug studies.
    Valente KP; Khetani S; Kolahchi AR; Sanati-Nezhad A; Suleman A; Akbari M
    Drug Discov Today; 2017 Nov; 22(11):1654-1670. PubMed ID: 28684326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of nanoparticle drug delivery systems with microfluidics tools.
    Khan IU; Serra CA; Anton N; Vandamme TF
    Expert Opin Drug Deliv; 2015 Apr; 12(4):547-62. PubMed ID: 25345543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Vitro Models of Biological Barriers for Nanomedical Research.
    Carton F; Malatesta M
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of nanoparticles via microfluidic devices and integrated applications.
    Yao F; Zhu P; Chen J; Li S; Sun B; Li Y; Zou M; Qi X; Liang P; Chen Q
    Mikrochim Acta; 2023 Jun; 190(7):256. PubMed ID: 37301779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microfluidics in nanoparticle drug delivery; From synthesis to pre-clinical screening.
    Ahn J; Ko J; Lee S; Yu J; Kim Y; Jeon NL
    Adv Drug Deliv Rev; 2018 Mar; 128():29-53. PubMed ID: 29626551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.